Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × Panobinostat × Clear all

NCT00985946 2019-12-09

Study of Panobinostat in Patients With Neuroendocrine Tumors

Phase 2 Terminated

15 enrolled 11 charts

Neuroendocrine Tumors